171 related articles for article (PubMed ID: 7474438)
1. [Application of molecular diagnosis to human lung cancer].
Isobe T
Rinsho Byori; 1995 Aug; 43(8):792-8. PubMed ID: 7474438
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in mouse lung tumors: implications for cancer chemoprevention.
Herzog CR; Lubet RA; You M
J Cell Biochem Suppl; 1997; 28-29():49-63. PubMed ID: 9589349
[TBL] [Abstract][Full Text] [Related]
3. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
Osada H; Takahashi T
Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883
[TBL] [Abstract][Full Text] [Related]
5. [Genetic abnormalities in lung cancer and their prognostic implications].
Mitsudomi T; Takahashi T
Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
7. Molecular lesions as targets for diagnosis and therapy of lung cancer.
Mitsudomi T
Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():112-6. PubMed ID: 11890096
[TBL] [Abstract][Full Text] [Related]
8. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
Minamoto T; Mai M; Ronai Z
Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
[TBL] [Abstract][Full Text] [Related]
9. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor genes in human lung cancer.
Shimizu E; Sone S
J Med Invest; 1997 Aug; 44(1-2):15-24. PubMed ID: 9395713
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic tumor markers in non-small cell lung cancer.
Oyama T; Osaki T; Baba T; Nagata Y; Mizukami M; So T; Nakata S; Ichiki Y; Uramoto H; Sugaya M; Yoshimatsu T; Morita M; Hanagiri T; Sugio K; Kawamoto T; Yasumoto K
Anticancer Res; 2005; 25(2B):1193-6. PubMed ID: 15865065
[TBL] [Abstract][Full Text] [Related]
12. Oncogenes and growth factors in human lung cancer.
Kern JA; Filderman AE
Clin Chest Med; 1993 Mar; 14(1):31-41. PubMed ID: 8462246
[TBL] [Abstract][Full Text] [Related]
13. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
[TBL] [Abstract][Full Text] [Related]
14. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
15. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
[TBL] [Abstract][Full Text] [Related]
16. p53 and lung cancer.
Brambilla E; Brambilla C
Pathol Biol (Paris); 1997 Dec; 45(10):852-63. PubMed ID: 9769949
[TBL] [Abstract][Full Text] [Related]
17. The molecular and cellular basis of human lung cancer.
Gazdar AF
Anticancer Res; 1994; 14(1B):261-7. PubMed ID: 8166465
[TBL] [Abstract][Full Text] [Related]
18. [The molecular diagnosis of cancer].
Barrera Saldaña H; Martínez Garza S; Ortiz López R
Rev Invest Clin; 2003; 55(2):128-37. PubMed ID: 12827915
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer.
Bennett WP; Hussain SP; Vahakangas KH; Khan MA; Shields PG; Harris CC
J Pathol; 1999 Jan; 187(1):8-18. PubMed ID: 10341702
[TBL] [Abstract][Full Text] [Related]
20. [Lung cancer].
Haugen A
Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2362-5. PubMed ID: 9691805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
